| S7505 |
(S)-crizotinib
|
(S)-crizotinib, the (S)-enantiomer of crizotinib, is a potent MTH1 (NUDT1) inhibitor with IC50 of 72 nM in a cell-free assay.
|
-
SLAS Discovery, 2026 Feb, 100291
-
SLAS Discovery, 2025, 100291
-
iScience, 2024, 27(10):110862
|
|
| S7631 |
TH287
|
TH287 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 0.8 nM.
|
-
Nucleic Acids Research, May 13, 2024, 6532–6542
-
Nat Commun, 2024, 15(1):2377
-
Nucleic Acids Research, 2024, 6532-6542
|
|
| S7632 |
TH588
|
TH588 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 5 nM. It has no relevant inhibition of any of the other tested proteins at 100 μM, although this compound showed reasonable selectivity when tested on a much larger panel of 87 enzymes, GPCRs, kinases, ion channels and transporters at 10 μM.
|
-
Oncology Letters, December 29, 2017, 3240-3244
-
Adv Healthc Mater, 2024, e2402349.
-
Advanced Healthcare Materials, 2024, e2402349
|
|